Strategies for effective patient services programs

Patient adherence to therapy continues to be a challenge for pharmaceutical manufacturers. New complex patient journeys and multi-channel brand distribution models make it increasingly difficult to address patient barriers to adherence. Manufacturers continue to spend millions of dollars on patient […]

Read More

More Than Ever, New Therapies Require Reimbursement Support

(sponsored by RxCrossroads by McKesson) Reimbursement in the specialty therapy arena is complex. In this current environment of heightened competition, rising prices and the growth of highly specialized, complex therapies, biopharma companies need assistance maneuvering the ever-changing landscape of reimbursement […]

Read More